Randomized Trial Sorafenib-Pravastatin Versus Sorafenib Alone for the Palliative Treatment of Child-Pugh A Hepatocellular Carcinoma

NCT01903694 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

474

Enrollment

OTHER

Sponsor class

Conditions

Child-Pugh A Hepatocellular Carcinoma

Interventions

DRUG: Sorafenib + Pravastatin
DRUG: Sorafenib

Sponsor

Centre Hospitalier Universitaire Dijon